Sellers EM - Search Results

1

Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.

Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, Sellers EM, Tyndale RF. Rao Y, et al. Among authors: sellers em. Mol Pharmacol. 2000 Oct;58(4):747-55. doi: 10.1124/mol.58.4.747. Mol Pharmacol. 2000. PMID: 10999944

2

Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.

Tyndale RF, Sellers EM. Tyndale RF, et al. Among authors: sellers em. Ther Drug Monit. 2002 Feb;24(1):163-71. doi: 10.1097/00007691-200202000-00026. Ther Drug Monit. 2002. PMID: 11805739 Review.

3

CYP2A6 genetic variation and potential consequences.

Xu C, Goodz S, Sellers EM, Tyndale RF. Xu C, et al. Among authors: sellers em. Adv Drug Deliv Rev. 2002 Nov 18;54(10):1245-56. doi: 10.1016/s0169-409x(02)00065-0. Adv Drug Deliv Rev. 2002. PMID: 12406643 Review.

4

Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration.

Schoedel KA, Sellers EM, Palmour R, Tyndale RF. Schoedel KA, et al. Among authors: sellers em. Mol Pharmacol. 2003 Jan;63(1):96-104. doi: 10.1124/mol.63.1.96. Mol Pharmacol. 2003. PMID: 12488541

5

Decreasing smoking behaviour and risk through CYP2A6 inhibition.

Sellers EM, Tyndale RF, Fernandes LC. Sellers EM, et al. Drug Discov Today. 2003 Jun 1;8(11):487-93. doi: 10.1016/s1359-6446(03)02704-1. Drug Discov Today. 2003. PMID: 12818518 Review.

6

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF. Schoedel KA, et al. Among authors: sellers em. Pharmacogenetics. 2004 Sep;14(9):615-26. doi: 10.1097/00008571-200409000-00006. Pharmacogenetics. 2004. PMID: 15475735

7

Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.

Malaiyandi V, Sellers EM, Tyndale RF. Malaiyandi V, et al. Among authors: sellers em. Clin Pharmacol Ther. 2005 Mar;77(3):145-58. doi: 10.1016/j.clpt.2004.10.011. Clin Pharmacol Ther. 2005. PMID: 15735609 Review.

8

Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method.

Mwenifumbo JC, Myers MG, Wall TL, Lin SK, Sellers EM, Tyndale RF. Mwenifumbo JC, et al. Among authors: sellers em. Pharmacogenet Genomics. 2005 Mar;15(3):189-92. doi: 10.1097/01213011-200503000-00008. Pharmacogenet Genomics. 2005. PMID: 15861044

9

Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics.

Al Koudsi N, Mwenifumbo JC, Sellers EM, Benowitz NL, Swan GE, Tyndale RF. Al Koudsi N, et al. Among authors: sellers em. Eur J Clin Pharmacol. 2006 Jun;62(6):481-4. doi: 10.1007/s00228-006-0113-3. Epub 2006 Apr 28. Eur J Clin Pharmacol. 2006. PMID: 16758265

10

CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.

Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF. Malaiyandi V, et al. Among authors: sellers em. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1812-9. doi: 10.1158/1055-9965.EPI-05-0723. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters